Rosalind Franklin University Expands Innovation with Tolmar's New Lab in Illinois

In a significant development for the pharmaceutical sector, Rosalind Franklin University (RFU) has officially welcomed the Northern Illinois Laboratory for Tolmar, Inc., a recognized specialty pharmaceutical company, to its Innovation and Research Park (IRP) in North Chicago, Illinois. This new laboratory represents not only a substantive expansion of Tolmar's capabilities but also deepens RFU's commitment to fostering an environment of industry-focused innovation.

Founded in 2007, Tolmar has gained international recognition for its expertise in long-acting injectable drug delivery systems, especially in the urology, oncology, and endocrinology sectors. The company is known for its leading product aimed at treating advanced prostate cancer, which is currently marketed in 89 countries.

The establishment of the new Illinois lab will bolster Tolmar's operational framework by complementing its existing team of researchers and engineers in Colorado, thus allowing for a more versatile approach to drug development. The site not only marks Tolmar’s increased presence in the Midwest but also adds to its executive and marketing resources situated in near Buffalo Grove, Illinois.

According to Dr. Dave Loffredo, the Vice President of Innovation at Tolmar, the move to RFU's IRP was a strategic decision following a thorough search for a location that would enhance the company's development capacities. He expressed enthusiasm about the array of collaboration opportunities available within the vibrant research environment. “Tolmar scientists are eager to be a part of this dynamic research setting and are hopeful about expanding our presence here,” he stated.

In addition to the advantages of location, the partnership provides Tolmar with access to state-of-the-art facilities and leading researchers in various scientific disciplines. Dr. Stace Porter, Senior Vice President of Development Operations at Tolmar, emphasized the potential offered by the RFU lab, including collaboration with top-tier scientists and advanced research cores. He further highlighted the advantages of RFU's location amid Lake County's flourishing global life sciences network.

The RFU’s Innovation and Research Park boasts 100,000 square feet of modern research facilities that house multiple research centers, including the Center for Cancer Cell Biology and Immunology and Infection. This infrastructure supports an innovative atmosphere that Dr. Joseph DiMario, Executive Vice President for Research at RFU, believes is crucial for the future of product development.

DiMario expressed RFU's excitement in adding Tolmar to its list of collaborative enterprises, stating, “We look forward to partnerships that will boost new product innovations. The IRP is designed to foster the kind of intellectual collaborations that can lead to groundbreaking advancements in biomedical research.”

Tolmar, being a fully integrated specialty pharmaceutical entity, is focused on the comprehensive journey from drug development and manufacturing to commercialization across various therapeutic domains. With primary offices located in Buffalo Grove and manufacturing centers in Northern Colorado, Tolmar’s efforts contribute substantially to addressing medical needs across critical health sectors.

In closing, the partnership between Tolmar and RFU signifies a promising era of scientific collaboration that is poised to generate significant advancements in pharmaceutical development and patient care.

For further insights into Tolmar and its initiatives, visit www.tolmar.com.

About Rosalind Franklin University

Rosalind Franklin University, named after the notable Dr. Rosalind Franklin, is deeply committed to advancing education and research across various health-related fields, including neuroscience, diabetes, and obesity. The institution includes several colleges focused on health professions and medicine, fostering an environment rich in research and educational opportunities. Explore more at rosalindfranklin.edu.